HYPERTROPHIC CARDIOMYOPATHY is a disease of cardiac muscle characterized by asymmetric septal hypertrophy (ASH).1-7 While the majority of patients with hypertrophic cardiomyopathy have no obstruction to left ventricular outflow,3 others show dynamic outflow obstruction due to systolic anterior motion of the anterior mitral leaflet (SAM). [8] [9] [10] Recently we observed five patients with dynamic subaortic obstruction due to SAM who had concentric hypertrophy, rather than ASH, present on echocardiographic study. In this investigation the clinical, hemodynamic and morphologic features of these patients are described and their relation to patients with typical hypertrophic cardiomyopathy is defined.
Materials and Methods
This report is based on five patients studied at the National Heart, Lung, and Blood Institute between 1974 and 1976. While each patient had cardiac hypertrophy and systolic anterior motion of the anterior mitaral leaflet, none had typical echocardiographic features of hypertrophic cardiomyopathy. 3 Of the five patients, three were men and two were women. Their ages were 33, 47, 56, 57 and 64 years. Each patient had hemodynamic and left ventricular angiographic studies. In each patient catheterization of the left ventricle was accomplished by the retrograde approach. In one patient (R.B.), biventricular cineangiography was performed to determine whether the configuration of the ventricular septum was typical of patients with hypertrophic cardiomyopathy.1" Four patients (B.Z., L.B., H.W., and M.N.) underwent left ventricular myotomy-myectomy because of incapacitating symptoms. ditions or with provocation. Each patient had echocardiographically documented systolic anterior motion of the anterior mitral leaflet, which was apparently responsible for the outflow obstruction, and concentric left ventricular wall thickening (septal-free wall thickness ratio of < 1.3). Two of the five patients had evidence of genetically transmitted hypertrophic cardiomyopathy, as evidenced by disorganized muscle cells in the ventricular septum or asymmetric septal hypertrophy in first degree relatives. Hence, left ventricular outflow tract obstruction associated with systolic anterior motion of the anterior mitral leaflet may occur in some patients with concentric left ventricular hypertrophy who do not have typical hypertrophic cardiomyopathy.
Echocardiograms were performed in each patient and in 19 first degree relatives of two patients (R.B. and L.B. In each of the five study patients echocardiograms showed the mitral valve to be positioned anteriorly in the left ventricular cavity, as evidenced by an abnormal mitral valve position index.17 Percent systolic thickening of the ventricular septum was diminished and the left atrium was enlarged (table 2); each of these findings has been associated with, but is not diagnostic of, hypertrophic cardiomyopathy. Echocardiographic evidence of mitral valve prolapse was not present in any of the five patients. Neither of the two patients studied at necropsy had significant (> 50% cross-sectional area) coronary arterial luminal narrowing. Discussion This study demonstrates that left ventricular outflow tract obstruction due to SAM may occur in patients with concentric left ventricular hypertrophy. Subaortic obstruction due to SAM is generally considered to occur, with rare exception, only in patients having hypertrophic cardiomyopathy with ASH.3 The question naturally arises as to whether the cardiac disease manifested by these patients is part of the disease spectrum of hypertrophic cardiomyopathy. In this regard, disorganized cardiac muscle cells, which in our experience are characteristic of patients with genetically transmitted hypertrophic cardiomyopathy,13"15 were absent from the ventricular septum of the two patients without a family history of hypertrophic cardiomyopathy. In addition, echocardiographic studies did not disclose ASH in 19 first degree relatives of two of these patients (including one patient in whom ventricular septal tissue was not available for analysis). The absence of echocardiographically determined ASH in a large number of first degree relatives of a patient suggests that genetically transmitted hypertrophic cardiomyopathy is not present. Hence, three of our five patients with concentric hypertrophy do not appear to be part of the disease spectrum of familial hypertrophic cardiomyopathy, even though they demonstrate subaortic obstruction due to SAM.
In contrast, patients M.N. and H.W., who also had con- Lastly, the possibility must be raised that the pressure gradients measured at cardiac catheterization in our patients were due to catheter entrapment23 in a hypertrophied heart, rather than to true outflow obstruction. However, during hemodynamic measurements in our patients, blood could be withdrawn and contrast ejected through the catheter (of which the tip was free in the left ventricular cavity) during the entire cardiac cycle. Also, the left ventricular pressure contour was not damped or distorted, suggesting that the catheter was not recording intramural pressures.23 24 
